• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肺癌患者的癌症恶病质综合征]

[Cancer cachexia syndrome in patients with lung cancer].

作者信息

Jankowska Renata, Kosacka Monika

机构信息

Katedry i Kliniki Chorób Płuc Akademii Medycznej we Wrocławiu.

出版信息

Wiad Lek. 2003;56(7-8):308-12.

PMID:14969155
Abstract

UNLABELLED

Cancer cachexia syndrome is a common and important complication of cancer. It occurs in 30% to 80% cancer patients. It includes anorexia, loss weight, weakness and impaired immune function. The cause of the syndrome stays still unclear. Many endocrinological and metabolic abnormalities are observed, like hypermetabolism, glucose intolerance, increased proteolysis and lipolysis. Main role in the development of cancer cachexia is played by cytokines: TNF, interleukin 1 and 6, interferon alfa and gamma. The aim of the study was to collect information about cachexia in lung cancer patients, treated in Department of Pulmonology, Wrocław Medical University. We observed 76 patients with recent diagnosis of lung cancer (43 male, 33 female), 50 patients with non-small lung cancer and 26 with small lung cancer. Average age 61 +/- 9.76. We divided all patients in four groups, depending on percent of weight loss and compared these groups. We estimated extent of disease, anthropological and biochemical parameters. Among all patients we found cachexia in 23 (32%). There were only some differences between patients with and without cachexia. Bigger loss weight was observed in older men.

CONCLUSIONS

Cachexia syndrome is not an important problem in lung cancer patients at the time of diagnosis.

摘要

未标注

癌症恶病质综合征是癌症常见且重要的并发症。它发生在30%至80%的癌症患者中。其表现包括厌食、体重减轻、虚弱和免疫功能受损。该综合征的病因仍不清楚。观察到许多内分泌和代谢异常,如高代谢、葡萄糖不耐受、蛋白水解和脂肪分解增加。细胞因子在癌症恶病质的发展中起主要作用:肿瘤坏死因子、白细胞介素1和6、干扰素α和γ。本研究的目的是收集弗罗茨瓦夫医科大学肺病科治疗的肺癌患者恶病质的相关信息。我们观察了76例近期诊断为肺癌的患者(43例男性,33例女性),50例非小细胞肺癌患者和26例小细胞肺癌患者。平均年龄61±9.76岁。我们根据体重减轻的百分比将所有患者分为四组,并对这些组进行比较。我们评估了疾病程度、人体测量和生化参数。在所有患者中,我们发现23例(32%)有恶病质。有恶病质和无恶病质的患者之间仅有一些差异。老年男性体重减轻更明显。

结论

恶病质综合征在肺癌患者诊断时并非重要问题。

相似文献

1
[Cancer cachexia syndrome in patients with lung cancer].[肺癌患者的癌症恶病质综合征]
Wiad Lek. 2003;56(7-8):308-12.
2
[The incidence and pathogenesis of cancer anorexia-cachexia syndrome in lung cancer].[肺癌中癌症厌食-恶病质综合征的发病率及发病机制]
Pneumonol Alergol Pol. 2008;76(5):360-5.
3
[VEGF in the cancer anorexia-cachexia syndrome in patients with lung cancer].[血管内皮生长因子在肺癌患者癌症恶病质综合征中的作用]
Pneumonol Alergol Pol. 2006;74(2):186-90.
4
[Anorexia-cachexia syndrome in lung cancer].[肺癌中的厌食-恶病质综合征]
Pneumonol Alergol Pol. 2008;76(5):311-2.
5
Expression and clinicopathologic significance of proteolysis-inducing factor in non-small-cell lung cancer: an immunohistochemical analysis.蛋白酶诱导因子在非小细胞肺癌中的表达及其与临床病理特征的关系:免疫组化分析。
Clin Lung Cancer. 2010 Sep 1;11(5):346-51. doi: 10.3816/CLC.2010.n.044.
6
Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients.促炎细胞因子和氧化应激/抗氧化参数表征了肺癌患者早期恶病质的生物体液特征。
Oncol Rep. 2007 Dec;18(6):1521-7.
7
A clinicopathological study of the paraneoplastic neuromuscular syndromes associated with lung cancer.一项关于与肺癌相关的副肿瘤性神经肌肉综合征的临床病理研究。
Q J Med. 1990 Jun;75(278):577-95.
8
Impact of TNF-alpha and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients.肿瘤坏死因子-α和白细胞介素-6水平对新诊断非小细胞肺癌患者恶病质发生发展的影响。
Am J Clin Oncol. 2006 Aug;29(4):328-35. doi: 10.1097/01.coc.0000221300.72657.e0.
9
Erlotinib plus parenteral nutrition: an opportunity to get through the hardest days of advanced non-small cell lung cancer with cancer anorexia-cachexia syndrome.厄洛替尼联合肠外营养:应对晚期非小细胞肺癌伴癌症恶病质综合征最艰难日子的契机。
Am J Hosp Palliat Care. 2013 Mar;30(2):210-3. doi: 10.1177/1049909113476930. Epub 2013 Feb 6.
10
What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated?胰岛素样生长因子系统在癌症恶病质的病理生理学中起什么作用,以及它是如何被调节的?
Clin Endocrinol (Oxf). 2002 Jun;56(6):723-33. doi: 10.1046/j.1365-2265.2002.01540.x.

引用本文的文献

1
Effect of omega 3 fatty acids on C-reactive protein and interleukin-6 in patients with advanced nonsmall cell lung cancer.ω-3脂肪酸对晚期非小细胞肺癌患者C反应蛋白和白细胞介素-6的影响。
Medicine (Baltimore). 2018 Sep;97(37):e11971. doi: 10.1097/MD.0000000000011971.